≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

Endpoint Browser PheWeb

C3_EYE_ADNEXA_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C69
  • Hospital discharge: ICD-9 — 190
  • Hospital discharge: ICD-8 — 190
  • Cause of death: ICD-10 — C69
  • Cause of death: ICD-9 — 190
  • Cause of death: ICD-8 — 190
  • Cancer registry: Topography ICD-O-3 — C69
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

568

4. Check minimum number of events

None

568

5. Include endpoints

None

568

6. Filter based on genotype QC (FinnGen only)

568

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 568 260 308
Unadjusted period prevalence (%) 0.11 0.09 0.14
Median age at first event (years) 62.65 60.04 64.85

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
259
Matched controls
2588
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
155.3
133
*
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
+∞
137.0
119
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
+∞
137.0
119
*
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
+∞
121.7
107
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
92.9
117.5
126
26
WX140
NOMESCO Finland
Parabulbar anesthesy
36.8
77.9
101
44
XCK10
NOMESCO Finland
Photography of fundus of eye
16.8
73.4
131
148
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
201.9
73.3
73
5
C69.3
ICD-10 Finland
Malignant neoplasm: Choroid
+∞
71.2
65
*
8720/3-C69.9
ICD-O-3
Malignant melanoma, NOS, of eye, NOS
+∞
70.0
64
*
8720/3-C69.3
ICD-O-3
Malignant melanoma, NOS, of choroid
+∞
67.7
62
*
130
Kela drug reimbursment
Malignant tumour
+∞
59.7
55
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
17.9
55.3
91
76
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
46.2
43
*
H02AB02
ATC
dexamethasone; systemic
55.6
39.4
46
10
WX002
NOMESCO Finland
Sedation and analgesia
7.0
38.9
117
273
C69.39
ICD-10 Finland
Malignant tumor in chorioidea other or unspecified histology
+∞
37.4
35
*
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
114.2
36.9
39
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
36.3
34
*
WF002
NOMESCO Finland
Radical radiotherapy
398.1
35.9
35
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
8.8
34.9
82
129
A04AA02
ATC
granisetron; systemic, transdermal
366.7
32.6
32
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
31.9
30
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
31.9
30
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
7.0
30.8
86
172
A03FA01
ATC
metoclopramide; systemic, rectal
7.4
30.6
81
150
ZXA05
NOMESCO Finland
Left side
4.9
29.8
130
441
CFA20
NOMESCO Finland
Biopsy of conjunctiva
168.8
29.3
30
*
C69.02
ICD-10 Finland
Malignant tumor in conjunctival melanoma
+∞
28.7
27
*
9510/3-C69.2
ICD-O-3
Retinoblastoma, NOS, of retina
+∞
27.6
26
*
CAA30
NOMESCO Finland
Biopsy of orbit
+∞
26.5
25
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
50.0
26.2
31
7
JN4BD
NOMESCO Finland
Extensive body CT
10.3
25.9
53
63
Z51.5
ICD-10 Finland
Palliative care
16.0
25.1
41
30
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
8.8
24.5
55
77
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
+∞
24.3
23
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.8
23.4
91
260
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
23.3
22
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
23.3
22
*
CF2S4
NOMESCO Finland
Photography of conjunctiva
239.3
21.9
22
*
1906B
ICD-9 Finland
Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]
+∞
21.1
20
*
ZXA00
NOMESCO Finland
Right side
3.8
20.9
122
496
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.0
20.7
104
373
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
20.1
19
*
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
21.6
20.0
29
15
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
19.0
18
*
A04AA01
ATC
ondansetron; systemic, rectal
15.1
18.8
31
23
C61
ICD-10 Finland
Malignant neoplasm of prostate
204.1
18.8
19
*
S01ED51
ATC
timolol, combinations; ophthalmic
6.1
18.7
54
107
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
+∞
17.9
17
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
17.9
17
*
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
45.5
17.6
21
5
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
13.4
17.3
30
25
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
53.9
17.2
20
*
L01AX03
ATC
temozolomide; systemic
+∞
16.8
16
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
16.8
16
*
C69.21
ICD-10 Finland
Retina
+∞
16.8
16
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
181.1
16.7
17
*
N02AA05
ATC
oxycodone; systemic
4.6
16.5
63
170
XW000
NOMESCO Finland
Bone marrow biopsy
11.2
16.5
31
31
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
7.0
16.1
41
68
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
14.2
16.1
27
21
3770
FHL
Placing a radiating plate on the surface of the eye with additional measures
+∞
15.8
15
*
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
15.8
15
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
15.8
15
*
8000/3-C69.3
ICD-O-3
Neoplasm, malignant of choroid
+∞
15.8
15
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
15.8
15
*
C69.40
ICD-10 Finland
Malignant tumor of ciliary body without histology
+∞
15.8
15
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.0
15.7
141
740
JN4CD
NOMESCO Finland
Very extensive body CT
17.5
15.6
24
15
C69.42
ICD-10 Finland
Malignant tumor of ciliary melanoma
+∞
14.7
14
*
3779
FHL
Other operations in this group include disc removal
+∞
14.7
14
*
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
+∞
14.7
14
*
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
158.5
14.6
15
*
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
158.5
14.6
15
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
18.3
14.6
22
13
XX3DW
NOMESCO Finland
Time consuming IT work
7.2
14.3
35
55
CBA10
NOMESCO Finland
Biopsy of eyelid
45.2
14.3
17
*
CDC00
NOMESCO Finland
Enucleation of eye
+∞
13.7
13
*
115
Kela drug reimbursment
Breast cancer
+∞
13.7
13
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
13.7
13
*
180
Kela drug reimbursment
Interferon alfa
+∞
13.7
13
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
19.6
13.6
20
11
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
22.6
13.5
19
9
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
20.4
13.1
19
10
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
13.0
83
336
CD2S4
NOMESCO Finland
Photography of eye
73.5
12.7
14
*
C69.20
ICD-10 Finland
Retina
+∞
12.6
12
*
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
12.6
12
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
12.6
12
*
C69.09
ICD-10 Finland
Malignant tumor in conjunctival other or unspecified histology
+∞
12.6
12
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
12.6
12
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.6
12.3
126
683
JN6AD
NOMESCO Finland
CT of torso and neck
68.1
11.7
13
*
S01ED01
ATC
timolol; ophthalmic
7.2
11.6
28
43
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
11.5
11
*
C69.99
ICD-10 Finland
Malignant tumor in unspecified localization in eye or other unspecified histology
+∞
11.5
11
*
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
11.5
11
*
C69.03
ICD-10 Finland
Malignant tumor of conjunctival carcinoma
+∞
11.5
11
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
11.5
11
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
11.5
11
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.7
11.4
24
30
CA1ME
NOMESCO Finland
Ultrasound oculometry
29.4
10.8
14
5
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
10.5
10
*
CH2S4
NOMESCO Finland
Photography of iris
+∞
10.5
10
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
10.5
10
*
XX7GT
NOMESCO Finland
Selective internal radio therapy (SIRT) with Yttrium
+∞
10.5
10
*
116
Kela drug reimbursment
Prostate cancer
+∞
10.5
10
*
C69.60
ICD-10 Finland
Malignant tumor in orbit without histology
+∞
10.5
10
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.6
10.4
36
87
WX142
NOMESCO Finland
Sub-tenon anesthesy
24.5
10.3
14
6
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
10.2
130
766
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
12.9
10.0
17
14
Z97.0
ICD-10 Finland
Presence of artificial eye
57.2
9.7
11
*
H26.2
ICD-10 Finland
Complicated cataract
10.6
9.7
18
18
A06AH03
ATC
naloxegol; oral
103.6
9.5
10
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
9.4
9
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
9.4
9
*
C69.29
ICD-10 Finland
Retina
+∞
9.4
9
*
8720/3-C69.0
ICD-O-3
Malignant melanoma, NOS, of conjunctiva
+∞
9.4
9
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
9.4
9
*
JN4AD
NOMESCO Finland
Body CT examination
6.5
9.2
23
38
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
19.5
9.0
13
7
WZC30
NOMESCO Finland
Teaching
3.7
8.9
39
118
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
51.8
8.7
10
*
L02AE02
ATC
leuprorelin; implant, parenteral
51.8
8.7
10
*
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
51.8
8.7
10
*
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
28.6
8.5
11
*
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
20.9
8.5
12
6
C69.63
ICD-10 Finland
Malignant tumor of orbital carcinoma
+∞
8.4
8
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
19003
ICD-8 Finland
Malignant neoplasm of eye, Retinae
+∞
8.4
8
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.4
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
CAW99
NOMESCO Finland
Other operation on orbit
+∞
8.4
8
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
8.4
8
*
L02BB03
ATC
bicalutamide; oral
+∞
8.4
8
*
C69.2
ICD-10 Finland
Malignant neoplasm: Retina
+∞
8.4
8
*
1905A
ICD-9 Finland
Malignant neoplasm of eye, Retina[RETINOBLASTOMA RETINAE]
+∞
8.4
8
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
8.4
8
*
ZXA10
NOMESCO Finland
Bilateral
2.6
8.1
68
316
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.4
7.9
23
46
H33.0
ICD-10 Finland
Retinal detachment with retinal break
7.4
7.9
18
26
H05.2
ICD-10 Finland
Exophthalmic conditions
46.4
7.8
9
*
ZX120
NOMESCO Finland
Intravenous
4.1
7.6
29
78
L03AB05
ATC
interferon alfa-2b; parenteral
82.3
7.5
8
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
82.3
7.5
8
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
82.3
7.5
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
C69.45
ICD-10 Finland
Melanoma of iris
+∞
7.3
7
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
9591/3-C69.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of eye, NOS
+∞
7.3
7
*
CAD00
NOMESCO Finland
Exenteration of orbit with use of graft or flap
+∞
7.3
7
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
7.3
7
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
7.3
7
*
3102
FHL
Enucleation
+∞
7.3
7
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
7.3
7
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
6.4
7.2
18
30
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
7.1
44
170
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
11.4
6.9
12
11
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.6
6.8
52
228
HA1AA
NOMESCO Finland
X-ray mammography
7.5
6.8
15
21
CA1AD
NOMESCO Finland
Orbita CT
41.1
6.8
8
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
41.1
6.8
8
*
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
41.1
6.8
8
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
6.2
6.7
17
29
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
23.2
6.7
9
*
ZX112
NOMESCO Finland
Subcutaneous
23.2
6.7
9
*
XCD20
NOMESCO Finland
Photoangiography of eye
7.2
6.6
15
22
H43.1
ICD-10 Finland
Vitreous haemorrhage
7.2
6.6
15
22
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.5
6.6
16
26
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
71.5
6.5
7
*
C69.90
ICD-10 Finland
Malignant tumor in unspecified localization in eye without histology
+∞
6.3
6
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
6.3
6
*
C69.91
ICD-10 Finland
Malignant tumor in unspecified localization in the eye retinoblastoma
+∞
6.3
6
*
L03AA02
ATC
filgrastim; parenteral
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
+∞
6.3
6
*
CFD10
NOMESCO Finland
Repair of conjunctiva
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.3
6
*
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
6.3
6
*
L02BG04
ATC
letrozole; oral
27.4
6.3
8
*
WW500
NOMESCO Finland
Blood transfusion
8.9
6.1
12
14

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
113
111
12.46
104.72
1.7
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
309
1271
4.14
61.82
5.3
2.8
u/l
30.9
33.3
0.69
299
1207
(40768795) Lymph node Pathology biopsy report
25
11
23.73
34.27
1.5
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
100
290
3.97
30.64
1.4
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
247
1255
2.71
29.00
2.7
1.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
339
2045
2.63
27.57
10.7
3.9
umol/l
12.6
12.1
0.22
331
1925
(40768441) Liver Pathology biopsy report
27
22
12.84
27.41
1.3
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
83
237
3.93
25.82
3.4
1.4
ug/l
7.5
4.1
0.51
62
186
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
450
3209
2.94
24.79
13.8
5.4
u/l
86.4
77.3
2.26
429
2943
(3045142) Bone marrow Pathology biopsy report
28
31
9.45
23.14
1.5
1.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
245
1352
2.43
22.90
7.9
5.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
349
2269
2.40
22.19
15.7
6.3
e9/l
3.9
4.3
2.59
312
1974
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
26
6
45.25
21.58
1.3
1.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
44
89
5.27
21.00
2.2
1.7
u/ml
19.2
147.8
0.75
37
68
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
18
0
+∞
18.85
1.1
0.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
32
57
5.89
17.45
1.2
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
286
1828
2.14
17.40
6.5
3.9
g/l
34.7
35.4
1.33
264
1668
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
320
2166
2.09
16.37
9.2
6.0
mmol/l
1.2
1.2
0.55
265
1847
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
93
375
2.77
16.17
1.6
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
87
340
2.84
16.04
1.5
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
206
1209
2.10
15.19
3.1
2.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
19
22
8.90
15.09
2.5
1.7
e6/l
710.0
1016.2
—
9
9
(3012095) Magnesium [Moles/volume] in Serum or Plasma
128
627
2.34
14.72
4.1
3.3
mmol/l
0.8
0.8
0.61
123
575
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
14
0
+∞
14.64
1.1
0.0
%
35.6
—
—
14
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
14
0
+∞
14.64
1.0
0.0
%
8.9
—
—
14
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
25
42
6.18
14.43
2.3
1.6
u/ml
7.2
90.8
0.46
25
42
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
290
1953
1.99
14.39
8.2
5.6
mmol/l
1.2
1.2
0.24
273
1727
(3022096) Basophils/100 leukocytes in Blood
275
1843
1.95
13.59
8.8
5.5
%
0.7
0.7
0.08
267
1698
(40758558) Short blood count panel - Blood
167
944
2.09
13.32
13.5
4.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
279
1893
1.93
13.16
8.9
5.6
%
3.0
3.0
0.12
271
1742
(3013115) Eosinophils [#/volume] in Blood
303
2117
1.92
13.04
9.1
5.5
e9/l
0.2
0.2
0.86
270
1854
(3019069) Monocytes/100 leukocytes in Blood
279
1899
1.92
12.98
9.3
5.8
%
9.3
8.8
1.55
271
1757
(3001604) Monocytes [#/volume] in Blood
294
2037
1.92
12.95
8.6
5.3
e9/l
0.6
0.6
0.32
262
1755
(3006315) Basophils [#/volume] in Blood
295
2048
1.92
12.89
8.6
5.3
e9/l
0.0
0.0
0.52
262
1771
(3019198) Lymphocytes [#/volume] in Blood
298
2081
1.91
12.74
8.7
5.3
e9/l
2.1
1.9
0.50
265
1823
(3002030) Lymphocytes/100 leukocytes in Blood
280
1935
1.88
12.18
9.2
5.7
%
27.3
27.4
0.09
271
1779
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
79
338
2.55
12.08
2.7
2.0
g/l
0.2
0.2
0.39
73
308
(3018010) Neutrophils/100 leukocytes in Blood
278
1922
1.87
12.03
8.7
5.5
%
56.6
57.4
0.45
268
1780
(3023368) Bacteria identified in Blood by Culture
191
1171
1.95
11.93
5.1
4.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
56
204
2.94
11.66
1.3
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
17
24
7.27
11.47
1.4
1.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
17
27
6.46
10.32
2.4
1.6
e9/l
1.2
0.9
—
8
15
(3015377) Calcium [Moles/volume] in Serum or Plasma
212
1402
1.82
10.13
6.8
2.1
mmol/l
2.3
2.4
0.22
187
1150
(3013826) Glucose [Moles/volume] in Serum or Plasma
342
2623
1.76
9.64
6.5
4.5
mmol/l
6.8
6.9
0.31
326
2440
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
259
1841
1.75
9.52
4.6
3.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
153
929
1.89
9.51
3.2
2.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
89
452
2.15
9.12
1.6
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
18
35
5.28
8.93
1.8
1.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
63
280
2.41
8.84
3.9
2.2
g/l
9.1
10.7
1.34
58
259
(3018418) pH of Serum or Plasma
186
1232
1.76
8.56
5.4
3.3
ph
7.4
7.4
0.11
44
201
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
13
8.61
8.49
1.1
1.1
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
12
16
7.64
8.44
2.6
1.3
e9/l
0.2
0.2
0.02
12
16
(3026782) Osmolality of Urine
138
862
1.79
7.65
3.1
2.6
mosm/kgh2o
496.4
537.1
1.64
122
705
(3032080) INR in Blood by Coagulation assay
248
1820
1.64
7.58
8.9
9.9
inr
1.2
1.3
2.72
72
495
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
24
68
3.64
7.50
4.0
3.1
%
53.8
58.4
0.69
24
68
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
14
26
5.50
7.28
2.1
1.3
ug/l
21.7
15.3
0.99
14
26
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
11
7
15.98
7.25
5.5
1.0
u/ml
23.6
13.7
—
11
7
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
192
1340
1.65
7.04
3.4
2.3
u/l
61.1
56.1
0.77
179
1242
(3030905) Polymorphonuclear cells [#/volume] in Blood
23
67
3.54
6.91
3.3
2.8
e9/l
4.0
4.6
0.42
23
67
(3002582) Erythrocytes [#/volume] in Urine
187
1306
1.64
6.79
3.4
3.1
e6/l
28.5
109.6
0.93
144
1009
(3027945) Reticulocytes/100 erythrocytes in Blood
95
551
1.87
6.63
2.6
2.3
%
1.6
1.8
0.82
89
482
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
21
5.82
6.61
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
21
60
3.60
6.49
1.4
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
211
1533
1.60
6.46
3.8
3.6
e6/l
70.5
107.6
0.64
151
1091
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
79
435
1.95
6.44
4.2
2.4
umol/l
10.7
8.3
0.32
64
371
(3042936) Bacteria identified in Isolate by Culture
101
613
1.79
6.07
2.1
2.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
49
232
2.22
5.96
2.8
1.3
g/l
1.5
1.2
0.29
41
215
(3004588) Protein electrophoresis panel - Serum or Plasma
59
303
2.06
5.84
2.5
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
34
138
2.56
5.81
1.9
3.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
73
408
1.91
5.69
3.0
2.3
e9/l
65.7
68.8
0.44
62
328
(3007853) Bacteria identified in Skin by Aerobe culture
85
502
1.82
5.58
2.0
1.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
167
1183
1.58
5.54
3.5
3.0
e6/l
0.5
0.4
0.10
130
887
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
93
566
1.77
5.52
3.0
2.5
%
21.8
24.0
0.90
81
479
(3008295) Osmolality of Serum or Plasma
15
38
4.03
5.47
1.7
1.5
mosm/kgh2o
284.9
273.3
0.92
15
27
(36304419) Bacteria [Presence] in Urine
162
1143
1.58
5.46
3.5
2.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
236
1819
1.51
5.29
13.8
8.4
e9/l
0.0
0.0
1.22
199
1482
(3051671) S100 calcium binding protein B [Mass/volume] in Serum
5
0
+∞
5.21
2.4
0.0
ug/l
0.1
—
—
5
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
207
1557
1.52
5.19
4.0
3.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
9
10.14
5.04
2.2
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
90
563
1.71
4.84
7.3
5.5
mmol/l
1.1
1.0
0.89
79
511
(3019225) pH of Specimen
74
438
1.79
4.82
5.9
3.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
64
363
1.86
4.78
4.5
1.6
g/l
64.9
67.0
1.17
59
322
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
121
820
1.60
4.77
5.2
2.2
mmol/l
2.5
2.4
0.89
106
695
(3004789) Transferrin [Mass/volume] in Serum or Plasma
95
609
1.67
4.66
3.0
2.4
g/l
2.3
2.3
0.03
90
563
(3026493) Urate [Moles/volume] in Serum or Plasma
161
1172
1.52
4.62
3.2
2.5
umol/l
6286.9
7594.7
0.11
141
989
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
19
64
3.04
4.59
1.2
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
34
157
2.24
4.43
3.7
2.5
g/l
0.3
0.3
0.10
15
49
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
73
444
1.74
4.33
3.4
3.2
—
—
—
0
0
(4062490)
13
36
3.67
4.22
1.6
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
30
135
2.29
4.16
2.7
1.3
g/l
0.5
0.4
0.16
25
116
(3017181) Myelocytes/100 leukocytes in Blood
53
299
1.85
4.04
6.6
3.7
%
0.7
0.6
0.21
22
68
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
100
673
1.59
4.03
2.8
2.9
e6/l
1.2
2.6
1.35
54
364
(3002179) Metamyelocytes/100 leukocytes in Blood
49
271
1.88
3.97
6.5
3.8
%
0.4
0.2
0.26
16
51
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
473
4316
1.57
3.95
23.3
13.5
mg/l
24.7
24.3
0.10
406
3367
(3037467) Urinalysis macro (dipstick) panel - Urine
348
2994
1.42
3.93
5.3
4.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
160
2.13
3.85
1.5
1.4
g/l
3.1
3.1
0.04
27
120
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
20
77
2.66
3.84
1.4
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
34
3.58
3.78
3.3
3.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
128
924
1.50
3.75
2.9
2.4
e6/l
4.0
5.1
1.03
115
797
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
105
727
1.55
3.73
2.0
1.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
50
286
1.82
3.66
6.4
3.8
%
0.0
0.0
0.00
21
63
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
58
348
1.74
3.63
2.1
2.0
u/l
34.8
31.7
0.13
48
283
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
173
2.03
3.51
1.5
1.3
g/l
7.7
7.6
0.13
29
123
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
173
2.03
3.51
1.5
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
24
106
2.32
3.50
1.5
1.6
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
9
18
5.06
3.38
4.2
1.3
u/l
259.8
214.7
—
9
18
(40765096) Chromosome analysis panel by Banding
7
10
7.07
3.37
1.3
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
16
59
2.76
3.35
1.3
1.5
u/ml
92.8
112.7
—
5
9
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
23
102
2.31
3.33
2.5
2.1
mg/l
12.9
11.9
0.31
23
97
(3026008) Bacteria identified in Urine by Culture
173
1349
1.41
3.33
3.1
3.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
65
2.67
3.33
1.2
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
43
3.07
3.27
1.5
2.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
173
1.96
3.16
1.5
1.3
g/l
3.5
3.9
1.34
27
118
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
16
61
2.67
3.16
1.2
1.5
u/ml
248.1
271.3
—
9
36
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
9
20
4.55
3.12
1.3
2.5
nmol/l
9.1
3.7
—
9
20
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
34
3.28
3.07
1.3
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
18
75
2.45
3.00
1.6
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
57
2.68
2.98
1.2
1.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
5
10.07
2.98
4.6
2.2
%
34.6
66.8
—
5
5
(3022145) Colonoscopy Study observation
60
387
1.62
2.89
1.3
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
116
862
1.43
2.89
8.3
4.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
130
2.05
2.85
2.8
6.2
u/ml
0.3
0.3
0.07
13
76
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
36
3.10
2.82
1.5
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
18
4.49
2.80
2.6
1.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
248
2093
1.33
2.79
3.9
3.8
estimate
0.0
0.0
0.00
50
339
(21494890) Protein electrophoresis panel - 24 hour Urine
10
31
3.27
2.78
1.8
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
95
685
1.46
2.77
3.0
2.4
umol/l
12.5
13.5
0.62
89
628
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
91
2.24
2.76
1.2
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
6
8.39
2.75
1.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
6
8.39
2.75
1.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
60
2.54
2.72
1.7
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
99
723
1.45
2.71
2.8
2.7
e6/l
1.2
1.1
0.06
54
414
(3051651) Icteric interference index of Serum or Plasma
8
19
4.25
2.68
7.6
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
130
1001
1.39
2.64
1.3
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
55
356
1.60
2.63
12.1
6.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
45
278
1.67
2.58
2.3
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
44
2.76
2.56
1.2
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
115
872
1.40
2.55
2.0
1.9
mg/l
1.3
1.2
0.29
94
676
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
7
7.19
2.55
1.2
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
11
5.50
2.55
2.7
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
34
195
1.79
2.53
2.0
1.7
g/l
1.5
1.6
0.17
27
171
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
22
109
2.06
2.49
2.8
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
26
3.50
2.49
1.4
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
74
519
1.49
2.49
1.7
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
110
1421
0.72
2.48
2.8
3.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
89
2.17
2.47
1.4
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
89
2.17
2.47
1.4
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
73
513
1.49
2.43
8.1
7.1
mmol/l
0.7
1.5
1.03
56
391
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
12
5.04
2.40
1.2
1.0
miu/ml
1420.0
1871.1
—
6
12
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
73
515
1.48
2.39
8.2
7.0
kpa
5.1
5.1
0.05
68
490
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
384
4164
0.76
2.38
6.3
6.5
mmol/mol
40.3
40.8
0.38
360
3820
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
22
3.67
2.37
1.9
3.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
24
126
1.94
2.34
3.7
1.3
mg/l
57.1
45.1
0.25
17
102
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
24
126
1.94
2.34
3.7
1.3
mg/l
23.4
32.6
1.55
17
102
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
73
518
1.47
2.32
1.8
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
66
459
1.50
2.32
5.8
3.3
mmol/l
1.8
2.0
0.24
53
363
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
416
4457
0.75
2.31
5.0
5.3
mmol/l
2.7
2.7
0.02
390
4062
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
9
5.59
2.21
1.2
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
9
5.59
2.21
5.4
2.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
195
0.40
2.21
1.8
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
401
4309
0.76
2.19
4.4
4.7
mmol/l
1.4
1.4
0.35
376
3919
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
489
4624
1.41
2.16
17.3
9.1
u/l
27.4
25.3
2.06
474
4423
(40768806) Pleura Pathology biopsy report
9
30
3.03
2.15
2.1
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
65
460
1.47
2.11
5.8
3.3
kpa
5.6
5.8
0.58
65
445
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
82
2.11
2.09
1.7
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
49
328
1.54
2.07
3.9
3.5
—
—
—
0
0
(4281824)
7
20
3.53
2.06
1.3
1.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
42
272
1.59
2.04
7.0
3.9
%
0.0
1.6
0.50
18
55
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
42
273
1.58
2.01
1.5
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
32
2.84
2.01
1.0
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
23
127
1.85
1.97
5.0
3.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
356
3244
1.26
1.92
4.8
4.1
mm/h
14.0
12.4
1.07
332
2949
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
34
213
1.63
1.90
12.0
11.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
408
4350
0.78
1.89
4.5
4.7
mmol/l
4.5
4.5
0.04
381
3984
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
34
2.67
1.87
1.7
1.3
—
—
—
0
0
(3015736) pH of Urine
195
1664
1.26
1.85
3.6
3.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
40
2.53
1.84
1.2
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
12
4.19
1.82
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
12
4.19
1.82
1.0
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
72
535
1.40
1.81
1.3
1.3
titre
982.9
543.6
0.54
14
137
(3051611) Lipemic interference index of Serum or Plasma
9
35
2.60
1.80
7.1
2.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
54
382
1.46
1.78
6.0
3.0
kpa
4.8
4.5
0.35
54
367
(3009261) Glucose [Presence] in Urine by Test strip
241
2115
1.24
1.77
4.0
3.8
estimate
0.0
0.0
0.50
51
332
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
41
2.46
1.76
2.8
2.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
297
2668
1.24
1.76
4.2
3.0
u/l
75.1
48.0
2.28
279
2462
(3021601) Nitrite [Presence] in Urine by Test strip
238
2088
1.24
1.75
5.0
5.2
estimate
0.0
0.0
0.00
49
337
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
213
1848
1.24
1.73
4.1
3.9
ng/l
30.6
79.2
1.11
160
1364
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
30
2.69
1.73
1.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
13
3.87
1.72
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
82
1.98
1.71
1.1
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
55
2.21
1.68
1.7
1.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
33
213
1.58
1.66
7.0
5.7
mmol/l
25.7
24.8
0.58
33
197
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
22
128
1.75
1.62
1.5
1.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
14
3.59
1.62
4.4
2.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
10
43
2.35
1.61
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
32
2.52
1.60
2.0
2.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
116
946
1.28
1.58
4.6
4.1
ng/l
334.1
362.7
0.04
98
778
(3045414) Leukocytes [Presence] in Urine
27
169
1.63
1.55
1.9
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
135
1126
1.26
1.53
4.2
4.0
estimate
0.0
0.0
0.50
45
334
(3028433) Virus identified in Specimen by Culture
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
392
4166
0.81
1.52
4.0
4.2
mmol/l
1.4
1.3
1.40
368
3758
(3022313) Gas panel - Capillary blood
36
243
1.51
1.51
6.3
5.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
45
2.24
1.47
1.4
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
95
763
1.29
1.46
2.7
1.3
g/l
2.2
2.7
1.64
56
437
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
98
1199
0.78
1.45
1.8
1.7
mmol/l
1.4
1.4
0.19
90
993
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
7
28
2.52
1.45
1.4
1.2
u/l
20.0
33.3
—
7
21
(3000012) Reticulocyte production index
6
22
2.75
1.44
1.2
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
88
1.84
1.43
1.7
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
287
0.58
1.42
1.5
1.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
40
2.27
1.40
1.1
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
43
308
1.43
1.37
6.0
5.0
mmol/l
2.2
1.8
0.23
35
227
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
17
2.96
1.36
1.0
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
16
90
1.80
1.34
5.0
1.3
—
—
—
0
0
(44790049)
9
42
2.16
1.34
1.9
1.7
—
—
—
0
0
(44806118)
9
42
2.16
1.34
1.9
1.7
—
—
—
0
0
(44790047)
9
42
2.16
1.34
1.9
1.7
—
—
—
0
0
(44790048)
9
42
2.16
1.34
1.9
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
61
1.99
1.33
1.2
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
34
2.37
1.29
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
34
2.37
1.29
1.8
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
37
261
1.45
1.28
1.6
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
44
322
1.40
1.26
6.0
5.0
ph
7.4
7.4
—
6
34
(3003434) Protein [Mass/volume] in Pleural fluid
10
49
2.06
1.22
1.8
1.3
g/l
36.8
24.7
—
10
41
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
19
2.65
1.22
1.6
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
37
2.18
1.22
1.4
1.1
—
—
—
0
0
(4024509)
8
38
2.12
1.19
1.6
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
38
2.12
1.19
1.6
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
172
1512
1.20
1.17
3.5
3.2
ng/l
1327.7
1632.1
0.86
154
1279
(3012441) Differential panel - Pleural fluid
8
39
2.07
1.15
1.5
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
51
390
1.34
1.13
1.7
1.8
%
1.9
1.6
0.72
43
334
(3005570) Glucose [Moles/volume] in Urine
11
58
1.91
1.12
2.2
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
52
667
0.76
1.12
1.3
1.2
u/ml
31.9
10.1
0.65
17
247
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
26
177
1.49
1.10
2.1
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
89
1.70
1.08
1.2
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
67
1.81
1.05
1.4
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
56
440
1.30
1.04
2.6
3.9
ng/l
333.7
235.1
0.66
50
409
(3011648) Oxygen content in Venous blood
7
34
2.07
1.03
4.9
2.0
%
8.3
11.1
—
7
34
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
417
4353
0.84
1.02
4.8
4.8
mmol/l
6.0
6.1
0.25
383
3917
(3002385) Erythrocyte distribution width [Ratio]
371
3502
1.17
1.02
27.6
16.0
%
14.1
13.7
4.65
365
3406
(3027273) Bicarbonate [Moles/volume] in Venous blood
35
257
1.39
1.01
2.0
2.8
mmol/l
24.5
25.3
0.73
35
250
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
24
165
1.47
0.98
1.8
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
23
2.18
0.98
1.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
23
2.18
0.98
4.2
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
23
2.18
0.98
4.2
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
46
356
1.32
0.97
2.7
2.2
ml/min/173m2
48.8
61.9
1.58
16
151
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
1.2
—
70.3
—
0
8
(3044242) Glucose [Moles/volume] in Arterial blood
0
32
0.00
0.95
0.0
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
81
678
1.23
0.92
25.7
27.2
inr
1.3
1.3
0.01
11
94
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
14
86
1.64
0.91
1.5
1.7
iu/l
1.7
4.6
—
6
31
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
33
435
0.74
0.88
2.0
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
57
695
0.80
0.85
1.3
1.3
iu/ml
44.3
36.0
0.24
21
221
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
31
1.95
0.84
2.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
31
1.95
0.84
2.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
31
1.95
0.84
2.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
65
1.71
0.83
1.2
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
116
1016
1.18
0.82
4.0
3.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
58
1.74
0.80
1.0
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
92
1061
0.84
0.79
1.7
1.7
pmol/l
534.2
21810176.1
1.00
78
862
(40761535) Cells panel - Urine sediment
47
377
1.27
0.79
5.3
3.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
20
140
1.44
0.78
2.8
1.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
27
0.00
0.77
0.0
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
34
1.77
0.76
1.7
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
124
1102
1.16
0.74
3.4
3.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
135
1502
0.87
0.74
3.8
3.3
mg/l
485.3
210.2
0.31
98
946
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
55
1.65
0.73
1.6
1.3
—
—
—
0
0
(3013512) EKG study
155
1404
1.14
0.71
3.9
4.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
40
1.76
0.71
1.3
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
16
110
1.47
0.69
3.6
3.7
mg/l
42.6
27.0
—
10
77
(3045424) Erythrocytes [Presence] in Urine
9
59
1.53
0.68
1.6
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
471
4581
1.16
0.68
26.0
16.5
mmol/l
139.5
139.7
0.88
457
4442
(3039443) Prostate specific Ag panel - Serum or Plasma
5
92
0.54
0.67
1.4
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
43
1.64
0.67
2.4
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
28
1.79
0.66
2.0
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
193
1782
1.13
0.66
2.4
2.3
nmol/l
80.4
77.8
0.57
176
1562
(3023103) Potassium [Moles/volume] in Serum or Plasma
472
4596
1.16
0.65
26.0
16.6
mmol/l
4.0
4.0
0.10
455
4448
(3017732) Neutrophils [#/volume] in Blood
35
280
1.27
0.62
2.5
3.0
e9/l
4.1
3.9
0.15
27
209
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
71
1.56
0.62
1.4
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
49
1.64
0.62
1.5
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
50
1.61
0.61
1.0
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
138
0.65
0.61
1.6
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
88
1.49
0.61
5.3
3.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
13
88
1.49
0.61
5.9
4.3
mmol/l
1.7
2.9
—
8
54
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
51
1.58
0.60
1.0
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
51
1.58
0.60
1.0
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
52
1.55
0.59
1.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
52
1.55
0.59
1.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
52
1.55
0.59
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
97
1.45
0.59
1.3
2.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
256
1.26
0.58
1.4
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
126
1144
1.13
0.57
2.2
2.2
mg/l
3.0
3.0
0.06
115
963
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
186
1992
0.90
0.54
2.3
2.1
pmol/l
93.6
94.3
0.07
102
1002
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
74
1.50
0.53
1.3
1.8
—
—
—
0
0
(3020891) Body temperature
26
205
1.28
0.53
6.2
4.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
66
1.52
0.53
4.5
2.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
146
1580
0.90
0.51
4.4
4.0
mg/mmol
17.9
7.6
1.37
103
1002
(3019060) Gas panel - Arterial blood
39
325
1.21
0.51
4.9
5.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
92
1.42
0.51
1.2
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
327
3139
1.10
0.51
4.3
4.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
65
1.39
0.50
1.1
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
416
4041
1.11
0.50
21.6
12.2
ml/min/173m2
76.3
75.6
0.25
362
3232
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
41
1.47
0.50
1.8
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
101
1.40
0.50
1.3
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
93
1.41
0.48
5.2
2.8
—
—
—
0
0
(4306422)
7
46
1.53
0.48
1.1
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
10
143
0.69
0.48
2.4
2.3
ug/min
849.8
70.3
—
5
87
(40768797) Stomach Pathology biopsy report
66
581
1.15
0.48
1.2
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
63
553
1.16
0.47
1.3
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
48
1.46
0.47
1.4
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
58
507
1.16
0.46
1.6
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
49
1.43
0.46
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
460
4500
1.12
0.46
19.1
13.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
77
1.44
0.46
1.9
1.1
—
—
—
0
0
(4034850)
21
165
1.28
0.45
17.7
11.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
50
1.40
0.45
2.0
3.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
50
1.40
0.45
1.3
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
24
193
1.25
0.44
1.7
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
50
435
1.16
0.43
2.5
2.2
ug/g
203.8
126.2
0.66
42
343
(3024731) MCV [Entitic volume]
490
4815
1.13
0.43
32.9
19.6
fl
91.6
91.3
0.59
479
4723
(3035941) MCH [Entitic mass]
490
4815
1.13
0.43
32.9
19.6
pg
30.4
30.4
0.12
479
4723
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
56
1.43
0.42
1.5
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
490
4816
1.13
0.42
33.1
19.7
e9/l
6.9
6.7
0.68
475
4649
(3026361) Erythrocytes [#/volume] in Blood
490
4816
1.13
0.42
33.0
19.7
e12/l
4.4
4.5
3.20
474
4646
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
57
1.41
0.42
1.3
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
58
1.38
0.41
1.5
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
391
4014
0.92
0.41
5.4
4.5
mu/l
1.9
2.0
1.34
362
3602
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
15
0.00
0.41
0.0
1.2
—
9.4
—
0
15
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
8
59
1.36
0.41
1.3
1.5
—
0.5
—
0
5
(3000963) Hemoglobin [Mass/volume] in Blood
490
4818
1.12
0.41
33.3
19.8
g/l
132.2
135.7
5.08
480
4723
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
60
1.34
0.40
1.3
1.5
nmol/l
0.5
0.6
—
8
53
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
88
1.37
0.40
1.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
172
1622
1.09
0.38
4.2
4.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
489
4813
1.12
0.37
33.1
19.7
e9/l
238.4
243.8
0.88
473
4662
(3009508) Creatinine [Moles/volume] in Urine
145
1544
0.92
0.37
3.6
3.2
mmol/l
7.3
7.5
0.15
119
1293
(3027008) Opiates [Presence] in Urine
10
72
1.40
0.37
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
71
1.27
0.36
1.4
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
135
1437
0.92
0.34
5.0
3.7
%
23.4
24.4
0.28
76
670
(3000764) Benzodiazepines [Presence] in Urine
10
73
1.38
0.34
1.4
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
73
1.38
0.34
1.4
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
23
275
0.83
0.34
1.7
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
338
3284
1.07
0.33
4.5
3.7
pmol/l
15.0
15.0
0.06
314
2940
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
49
436
1.14
0.33
1.3
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
186
0.80
0.31
1.7
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
52
1.35
0.31
2.4
2.2
%
93.2
90.7
—
7
52
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
55
1.28
0.30
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
54
488
1.12
0.29
2.3
2.4
ug/l
5.4
6.9
0.53
44
421
(3019832) Treponema pallidum Ab [Presence] in Serum
22
187
1.18
0.27
1.3
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
12
95
1.27
0.26
2.2
2.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
137
0.80
0.24
1.1
2.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
15
124
1.22
0.24
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
26
228
1.15
0.23
1.2
1.2
iu/ml
140.3
133.1
0.04
11
94
(4010399)
30
337
0.88
0.23
1.3
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
41
1.22
0.22
1.0
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
27
304
0.88
0.21
1.1
1.2
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
11
0.00
0.21
0.0
1.4
—
60.6
—
0
11
(3001186) Copper [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
16.9
—
0
10
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
5.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
2.0
—
0
10
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.0
—
49.8
—
0
12
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
12
0.00
0.21
0.0
2.4
—
1.2
—
0
12
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
390
3838
1.05
0.20
24.0
14.7
%
38.3
39.7
1.79
264
2545
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.2
—
0.8
—
0
9
(3004616) Nuclear Ab [Presence] in Serum
6
52
1.16
0.19
1.3
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
53
1.13
0.18
1.2
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
63
1.11
0.17
1.3
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
56
597
0.93
0.17
13.4
7.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
151
1460
1.05
0.16
2.6
2.1
u/l
190.6
212.1
0.16
140
1359
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
90
859
1.06
0.16
1.3
1.3
u/ml
0.5
1.9
2.72
15
227
(42529406) Shigella sp [Presence] in Stool by Culture
11
130
0.84
0.16
1.7
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
72
1.11
0.16
1.4
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
83
1.21
0.15
1.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
87
0.80
0.14
1.4
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
128
0.86
0.13
1.7
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
128
0.86
0.13
1.7
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
9
106
0.85
0.13
2.8
3.5
nmol/l
0.8
0.9
—
9
80
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
230
0.91
0.11
1.5
1.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
95
1.16
0.11
1.5
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
114
1173
0.96
0.10
1.8
1.5
nmol/l
20.6
21.0
0.09
104
992
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
45
1.11
0.10
1.4
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
30
281
1.07
0.09
1.7
2.3
nmol/l
10.0
15.0
2.40
25
248
(3003338) MCHC [Mass/volume]
359
3625
0.97
0.09
29.0
17.8
g/l
331.7
332.4
0.67
349
3598
(3026389) Candida sp identified in Specimen by Organism specific culture
5
48
1.04
0.09
1.2
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
15
136
1.11
0.08
1.9
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
10
88
1.14
0.08
2.0
3.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
11
123
0.89
0.08
1.7
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
19
205
0.92
0.08
1.4
1.8
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
8
78
1.03
0.07
1.5
1.6
mu/l
353.8
265.4
—
8
69
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
180
1773
1.02
0.07
5.4
3.9
ug/l
3.4
2.0
0.63
160
1573
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
83
0.84
0.07
1.0
1.1
u/l
29.5
21.7
—
7
71
(3019309) Folate [Moles/volume] in Red Blood Cells
102
997
1.03
0.07
1.9
1.8
nmol/l
1229.4
1174.0
0.26
85
739
(3021788) Differential panel - Synovial fluid
11
99
1.11
0.06
1.2
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
26
246
1.06
0.06
3.7
3.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
25
264
0.94
0.06
1.2
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
17
158
1.08
0.06
6.9
4.2
mmol/l
4.0
3.9
0.19
17
147
(4094501)
13
119
1.09
0.06
1.2
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
15
139
1.08
0.05
4.9
4.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
100
1.10
0.05
1.3
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
179
1775
1.01
0.03
3.2
2.7
ug/l
179.4
134.4
1.19
170
1607
(3022621) pH of Urine by Test strip
29
299
0.97
0.02
3.7
3.1
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
18
188
0.96
0.02
6.9
3.7
mmol/l
1.2
1.5
1.01
18
182
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
59
597
0.99
0.01
4.7
5.0
%
32.2
32.3
0.01
45
389
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
164
1.04
0.00
1.1
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
17
164
1.04
0.00
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
145
0.96
0.00
1.8
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
26
256
1.02
0.00
2.3
2.4
—
—
—
0
0
(3000492) Spirometry study
35
346
1.01
0.00
1.8
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
99
985
1.01
0.00
3.3
2.6
ug/l
0.8
0.8
0.01
74
659
(3019150) Specific gravity of Urine by Refractometry
100
996
1.00
0.00
4.7
4.1
kg/l
1.0
1.0
0.32
15
161
(1002224) Polysomnography panel
15
149
1.01
0.00
1.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
234
2335
1.00
0.00
2.5
2.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
30.2
—
0
8
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
39.8
—
0
5
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
53
0.94
0.00
1.2
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
78
0.90
0.00
1.6
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
9.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
99
0.91
0.00
1.2
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
6
63
0.95
0.00
3.0
4.0
umol/l
240.2
355.4
—
6
55
(3016330) Potassium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
76
0.92
0.00
1.9
2.6
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
94
0.96
0.00
1.1
1.2
—
2.5
—
0
8
(3035285) Chloride [Moles/volume] in Venous blood
7
78
0.90
0.00
1.9
2.5
mmol/l
106.4
104.4
—
7
78
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
14.0
—
0
9
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
78
0.90
0.00
1.9
2.5
mmol/l
4.0
4.1
—
7
78
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
80
1.00
0.00
1.3
2.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
68
0.88
0.00
1.8
2.7
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
23.1
—
0
6
(3007916) DNA double strand Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_EYE_ADNEXA_EXALLC – Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).